What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
Upcoming SlideShare
Loading in...5
×
 

What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

on

  • 564 views

This Kalorama Information report, What's Next in Biologics? represents our latest research into the market for non-vaccine biological drugs and the companies who compete in the market.

This Kalorama Information report, What's Next in Biologics? represents our latest research into the market for non-vaccine biological drugs and the companies who compete in the market.

Statistics

Views

Total Views
564
Views on SlideShare
564
Embed Views
0

Actions

Likes
0
Downloads
11
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015 What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015 Document Transcript

  • Whats Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015Published: June 2011No. of Pages: 150Price: $3995The future of the pharmaceutical market will be determined by biologics - drugs producedby natural organisms or recombinant techniques consisting of proteins and other productsderived from living organisms for the treatment or management of diseases or injuries.What are the products that lead the market now and what can we expect to see in thecoming years?This Kalorama Information report, Whats Next in Biologics? represents our latest researchinto the market for non-vaccine biological drugs and the companies who compete in themarket. The following are among the data points in this report:• Biopharmaceutical Pipeline for Significant Companies• Market Size of Biopharmaceuticals• Monoclonal Antibodies (mAbs)• Recombinant Hormones and Proteins (rDNA)• Interferons and• Other Biologics• Biopharmaceutical Market Forecast to 2015• Products in Development: New Compound vs. Additional Indications• Competitor Market Shares for Biopharmaceuticals• Autoimmune, Cancer, Cardiovascular and Hormone Treatments Market Sizes andCompetitor Shares• Drug Development Cost Progression• Leading Biotech Therapies by 2010 Revenues• Population and Healthcare Spending Trends• Select Biotechnology Drugs Approved for MarketingThe biologics industry encompasses a wide range of products including monoclonalantibodies, blood products, vaccines, and some diagnostics and devices. For the purpose of
  • this study, Kalorama Information has focuses on those biologics that are used in conjunctionwith or as a replacement to traditional pharmaceutical treatment. For example, treatmentsfor cancer, growth disorders, autoimmune diseases and blood disorders. This study excludesproducts such as vaccines—including prophylactic vaccines—which are covered in-depth inseparate Kalorama studies. The following is among the qualitative analysis found in thisreport:• The Role Government Incentives Will Play in the Future Biotech Market• Pharmaceutical Regulatory Exclusivity• Biosimilars: Where They Stand and What We Can Expect• The Largest Areas of Research for Biopharmaceuticals• Improvements in the Next Generation of Biologics• The Impact of Aging Populations on Biotechnology Market Development• Health Care Reform: What it Means• Recent Mergers, Acquisitions, and Collaborations• Contributors to R&D Success• Targeted Cancer Therapy• Genome Sequencing for Personalized Healthcare• The Role of Contract Research OrganizationsIn the traditional pharmaceutical market, the pipeline is struggling to produce strongtherapies and the growing number of drugs losing patent protection will more than offsetrevenues generated from new developments. For now, the biotechnology market is sparedthe impact of this setback as the path to generic or biosimilar development is more involvedand the number of biotechnology drugs facing generic competition remains limited.TABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARYBackgroundScope and MethodologySize and Growth of the MarketKey Issues and Trends Affecting the MarketLeading CompetitorsCHAPTER TWO: INTRODUCTIONOverview of the KidneyKidney DiseasesTreatment OptionsDialysisKidney TransplantThe Artificial KidneyComparison of Treatment Options
  • In-Center HemodialysisHome HemodialysisCAPD (Continuous ambulatory peritoneal dialysis)CCPD (Continuous Cycler Peritoneal Dialysis)IPD (Intermittent Peritoneal Dialysis)Kidney TransplantationEpidemiology and Demographic PatternsESRD TrendsDialysis Treatment DemandDialysis Treatment Preferences: Major CountriesCHAPTER THREE: ISSUES AND TRENDS AFFECTING THE MARKETOverviewWorld DemographicsPrevalence of Diabetes in China and IndiaHospital Admissions for InfectionIncreasing Life Expectancy WorldwideInsurance and Reimbursement IssuesReimbursement in the United StatesAccess to Care for Native Populations Around the GlobeTrends in Kidney TransplantationProduct Development and InnovationDialyzersNephera LtdPrismaflex System SoftwareXCorporeal, Inc.Implantable Artificial KidneyConsolidation and Joint Ventures in the IndustryHome DialysisHeat Disinfection for Water QualityDialysis Treatment and ComfortDialysis on Cruise ShipsCompany Commitments to the National Salt Reduction InitiativeCHAPTER FOUR: DIALYSIS EQUIPMENT AND SUPPLIES MARKETOverviewHemodialysis Products and SuppliesHD MachinesBlood LineDialyzer Market View slide
  • Hemodialysis Access Products MarketPeritoneal Dialysis Products and SuppliesPeritoneal Dialysis—A Part of Integrated CarePeritoneal Dialysis Transfer SetsPeritoneal Dialysis CathetersPeritoneal Dialysis MachinesFactors Affecting DemandInnovative ProductsFresenius Medical CareBaxter InternationalGambroMarket Overview by RegionUnited StatesJapanGermanyFranceUnited KingdomItalyCanadaIndiaChinaAustraliaMarket AnalysisMarket Analysis by CountryCompetitive SummaryCHAPTER FIVE: DIALYSIS SERVICES MARKETOverviewDialysis Service CentersLeading Suppliers and ServicesFresenius Medical CareDaVitaMarket Overview by RegionRegional Variation of Dialysis CostUnited StatesJapanGermanyFranceUnited KingdomItaly View slide
  • CanadaIndiaChinaAustraliaMarket AnalysisMarket Analysis by CountryCompetitive SummaryCHATPER SIX: MARKET AND COMPETITOR ANALYSISMarket OverviewMarket Analysis by CountryLeading CompetitorsCHAPTER SEVEN: LEADING MANUFACTURERSOverviewAsahi Kasai Kuraray MedicalB.Braun AGBaxter HealthcareBellcoDaVitaDiaverumFresenius Medical CareGambro ABKawasumi Laboratories Inc.Medionics InternationalNikkiso Europe GmbHCHATPER EIGHT: LIST OF MAJOR COMPANIESLIST OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARYTable 1-1: The Worldwide Dialysis Market, 2005-2015Figure 1-1: The Worldwide Dialysis Market, 2005-2015CHAPTER TWO: INTRODUCTIONTable 2-1: Composition of Plasma, Nephric Filtrate, and UrineFigure 2-1: Incidence of ESRD vs. Transplants in United StatesTable 2-2: Kidney Transplant Rates by Country (20 Countries), 2004-2008Table 2-3: Number of ESRD Patients by Geographical Market (United States, France, United Kingdom,
  • Japan, Canada, ROW) 2005-2008Table 2-4: ESRD Prevalence by Country (31 Countries), 2005-2008Figure 2-2: ESRD Prevalence by Country (31 Countries) 2008Table 2-5: Number of Dialysis Patients by Geographical Market (North America, Asia-Pacific, EAME, LatinAmerica) 2010Table 2-6: Dialysis Modality Preference (Hemodialysis, Home Hemodialysis, or Peritoneal Dialysis) in 33Selected Countries, 2007-2008Figure 2-3: Dialysis Modality Preference (Hemodialysis, Home Hemodialysis, or Peritoneal Dialysis) in 32Selected Countries, 2008CHAPTER THREE: ISSUES AND TRENDS AFFECTING THE MARKETTable 3-1: World Population by Selected Geographical Region, 2010 - 2050Figure 3-1: World Population by Selected Geographical Region, 2010-2050Table 3-2: Percent Population Over 65 by Year and Region, 2010-2050Figure 3-2: Estimated World Population by Age, 2010 and 2050Table 3-3: Diabetes StatisticsTable 3-4: Average Life Expectancy in Years by Country 1980 and 2011Figure 3-3: Average Life Expectancy in Years by Country 1980 and 2011Figure 3-5: Medicare Total ESRD Expenditures (in USD Billions), 2006-2008Figure 3-6: Annual Cost of Dialysis Care in the United States by Type of Expense (Composite TreatmentRate, Hospitalization, Epogen/Other Drugs, Physician Costs, Other) in Dollars and Percentage ShareTable 3-7: Comparison Between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)CHAPTER FOUR: DIALYSIS EQUIPMENT AND SUPPLIES MARKETFigure 4-1: Hemodialysis Patients by Selected Country (15 countries) Percentage of Total DialysisPatientsFigure 4-2: Worldwide Hemodialysis Machine Demand (Installed Capacity Units), 2005-2015Figure 4-3: Worldwide Market for Home-Use Hemodialysis Machines, (Installed Capacity in Units), 2005-2015Figure 4-4: Worldwide Blood Lines Market, Units in Millions, 2005-2015Figure 4-5: Worldwide Dialyzer Market, Modules in Millions, 2005-2015Table 4-1: Differences in Source of Access by Region (North America, Europe, Asia, Latin America/Africa)and Type (AV Graft, AV Fistula, Catheter), Percentage of PatientsFigure 4-6: Worldwide Fistula Needles Market, Units in Millions, 2005-2015Figure 4-7: Worldwide Hemodialysis Catheter Market, Units, 2005-2015Figure 4-8: Worldwide AV Graft Market, Patients, 2005-2015Figure 4-10: Peritoneal Dialysis Patients by Selected Country (15 countries) Percentage of Total DialysisPatientsFigure 4-11: Worldwide Peritoneal Transfer Set Market, Units, 2005-2015
  • Figure 4-12: Peritoneal Dialysis Machines Market, Units, 2005-2015Table 4-2: Leading Providers of Dialysis Equipment and Supplies, 2010Figure 4-13: Leading Providers of Dialysis Equipment and Supplies, 2010Table 4-3: Access Preferences in the United States Percentage of Patients by Access Type (AV Grafts, AVFistula, Catheter)Table 4-4: Access Preferences in Japan Percentage of PatientsTable 4-5: Access Preferences in Germany, Percentage of PatientsTable 4-6: Access Preferences in France Percentage of PatientsTable 4-7: Access Preferences in the U.K. Percentage of PatientsTable 4-8: Access Preferences in Italy Percentage of PatientsTable 4-9: Access Preferences in Canada, Percentage of PatientsTable 4-12: Access Preferences in Australia Percentage of PatientsTable 4-13: The Worldwide Market for Dialysis Products by Dialysis Type, 2005-2015Figure 4-14: The Worldwide Market for Dialysis Products by Dialysis Type, 2005-2015Table 4-14: Dialysis Product Market, Dollar Volume by Region, 2010Figure 4-15: Dialysis Product Market, Market Share by Region, 2010Table 4-15: Worldwide Hemodialysis Products Competitor Analysis, 2010Figure 4-16: Worldwide Hemodialysis Products Market Share, 2010 (% Market Share)Table 4-16: Worldwide Peritoneal Dialysis Products Competitor Analysis, 2010Figure 4-17: Worldwide Peritoneal Dialysis Products Market Share, 2010 (% Market Share)CHAPTER FIVE: DIALYSIS SERVICES MARKETFigure 5-1: Worldwide Dialysis Centers (Number of Facilities), 2001-2010Table 5-1: Leading Providers of Dialysis Services, 2010Figure 5-2: Leading Providers of Dialysis Services, 2010Figure 5-3: U.S. Dialysis Facilities (Number of Clinics), 1991-2006Figure 5-4: U.S. Dialysis Patients at Years End, 1991-2010Table 5-4: The Worldwide Market for Dialysis Services, 2005-2015Figure 5-5: The Worldwide Market for Dialysis Services, 2005-2015Table 5-5: Dialysis Service Market, Dollar Volume by Region, 2010Figure 5-6: Dialysis Service Market, Market Share by Region, 2010Table 5-6: Worldwide Dialysis Service Market, Competitor Analysis, 2010Figure 5-7: Worldwide Dialysis Service Market Share, 2010 (% Market Share)CHAPTER SIX: MARKET AND COMPETITOR ANALYSISTable 6-1: The Worldwide Dialysis Market by Type, 2005-2015Figure 6-1: The Worldwide Dialysis Market by Type, 2005-2015Figure 6-2: Dialysis Industry: Proportion Products vs Services, 2010Table 6-2: Dialysis Products and Services Market, Dollar Volume by Region, 2015Figure 6-3: Dialysis Products and Services Market, Dollar Volume by Region, 2010
  • Table 6-3: Worldwide Dialysis Product and Service Market, Dollar Volume by Competitor, 2006, 2008and 2010Figure 6-1: Worldwide Dialysis Product and Service Market by Company Performance, 2006-2010Figure 6-4: Worldwide Dialysis Product and Service Market Share, 2010 (% Market Share)About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004E-mail: sales@reportsnreports.comhttp://www.reportsnreports.comVisit our Market Research Blog